{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:17:09Z","timestamp":1778620629469,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T00:00:00Z","timestamp":1694908800000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["5U54GM115458-05"],"award-info":[{"award-number":["5U54GM115458-05"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006518","name":"University of Nebraska Medical Center","doi-asserted-by":"publisher","award":["UNMC BSL-3"],"award-info":[{"award-number":["UNMC BSL-3"]}],"id":[{"id":"10.13039\/100006518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["DA052845"],"award-info":[{"award-number":["DA052845"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI113883"],"award-info":[{"award-number":["R01 AI113883"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["NR-52384"],"award-info":[{"award-number":["NR-52384"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["53524"],"award-info":[{"award-number":["53524"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["NR-55672"],"award-info":[{"award-number":["NR-55672"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["-52281"],"award-info":[{"award-number":["-52281"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["USA-WA1\/2020"],"award-info":[{"award-number":["USA-WA1\/2020"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["53800"],"award-info":[{"award-number":["53800"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["hCoV-19\/USA\/PHC658\/2021"],"award-info":[{"award-number":["hCoV-19\/USA\/PHC658\/2021"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["5P30 GM127200"],"award-info":[{"award-number":["5P30 GM127200"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003187","name":"NSF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["MCB 1515346"],"award-info":[{"award-number":["MCB 1515346"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.nano.2022.102604","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T06:55:52Z","timestamp":1663052152000},"page":"102604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Modular nanoarray vaccine for SARS-CoV-2"],"prefix":"10.1016","volume":"46","author":[{"given":"Karen","family":"Zagorski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kabita","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Rajaiah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omalla A.","family":"Olwenyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya N.","family":"Bade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpan","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun","family":"Filliaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri L.","family":"Lyubchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddappa N.","family":"Byrareddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"38","key":"10.1016\/j.nano.2022.102604_bb0005","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.15585\/mmwr.mm7038e1","article-title":"Comparative effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising conditions \u2014 United States, March\u2013August 2021","volume":"70","author":"Self","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.nano.2022.102604_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102710","article-title":"Autoimmune hepatitis triggered by SARS-CoV-2 vaccination","volume":"123","author":"Vuille-Lessard","year":"2021","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.nano.2022.102604_bb0015","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12185-021-03190-y","article-title":"Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine","volume":"114","author":"Waqar","year":"2021","journal-title":"Int J Hematol"},{"issue":"3","key":"10.1016\/j.nano.2022.102604_bb0020","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00296-021-04792-9","article-title":"SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis","volume":"41","author":"Velikova","year":"2021","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.nano.2022.102604_bb0025","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.kint.2021.06.002","article-title":"Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine","volume":"100","author":"Masset","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.nano.2022.102604_bb0030","first-page":"1","article-title":"Recurrence of thrombotic thrombocytopenic purpura after mRNA-1273 COVID-19 vaccine administered shortly after COVID-19. Konstantopoulos K, ed","volume":"2021","author":"Karabulut","year":"2021","journal-title":"Case Rep Hematol"},{"issue":"12","key":"10.1016\/j.nano.2022.102604_bb0035","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jama.2021.13443","article-title":"Myocarditis and pericarditis after vaccination for COVID-19","volume":"326","author":"Diaz","year":"2021","journal-title":"JAMA"},{"issue":"3348","key":"10.1016\/j.nano.2022.102604_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0262-4079(21)01448-2","article-title":"Herd immunity to covid-19 may not be attainable in the UK A high vaccination rate will save many lives, but it probably won't be enough to stop covid-19 becoming a seasonal disease, finds Helen Thomson","volume":"251","author":"Thomson","year":"2021","journal-title":"New Sci"},{"issue":"7851","key":"10.1016\/j.nano.2022.102604_bb0045","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/d41586-021-00728-2","article-title":"Five reasons why COVID herd immunity is probably impossible","volume":"591","author":"Aschwanden","year":"2021","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.nano.2022.102604_bb0050","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.cell.2020.10.049","article-title":"Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer","volume":"183","author":"Avanzato","year":"2020","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.nano.2022.102604_bb0055","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1001\/jama.2021.7212","article-title":"Researchers tie severe immunosuppression to chronic COVID-19 and virus variants","volume":"325","author":"Abbasi","year":"2021","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.nano.2022.102604_bb0060","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1080\/23744235.2021.1939891","article-title":"SARS-CoV-2 late shedding may be infectious between immunocompromised hosts","volume":"53","author":"Kaila","year":"2021","journal-title":"Infect Dis"},{"key":"10.1016\/j.nano.2022.102604_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102506","article-title":"Autoinflammatory and autoimmune conditions at the crossroad of COVID-19","volume":"114","author":"Rodr\u00edguez","year":"2020","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.nano.2022.102604_bb0070","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/jvi.64.3.1407-1409.1990","article-title":"Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization","volume":"64","author":"Vennema","year":"1990","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.nano.2022.102604_bb0075","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3390\/v4091731","article-title":"Neutralization interfering antibodies: a \u201cnovel\u201d example of humoral immune dysfunction facilitating viral escape?","volume":"4","author":"Nicasio","year":"2012","journal-title":"Viruses"},{"issue":"22","key":"10.1016\/j.nano.2022.102604_bb0080","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1128\/JVI.78.22.12672-12676.2004","article-title":"Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets","volume":"78","author":"Weingartl","year":"2004","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.nano.2022.102604_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005271","article-title":"Tuberculosis in newborns: the lessons of the \u201cL\u00fcbeck Disaster\u201d (1929\u20131933)","volume":"12","author":"Fox","year":"2016","journal-title":"PLoS Pathog"},{"issue":"24","key":"10.1016\/j.nano.2022.102604_bb0090","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1056\/NEJMoa1008677","article-title":"Vaccine-derived poliomyelitis 12 years after infection in minnesota","volume":"364","author":"DeVries","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2022.102604_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.779453","article-title":"Inflammation and platelet activation after COVID-19 vaccines - possible mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis","volume":"12","author":"Ostrowski","year":"2021","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.nano.2022.102604_bb0100","article-title":"Clinical presentation and outcomes of myocarditis post mRNA vaccination: a meta-analysis and systematic review","volume":"13","author":"Matta","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.nano.2022.102604_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.517290","article-title":"Challenges of developing novel vaccines with particular global health importance","volume":"11","author":"Heaton","year":"2020","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.nano.2022.102604_bb0110","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41591-021-01301-0","article-title":"Vaccine development for emerging infectious diseases","volume":"27","author":"Excler","year":"2021","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.nano.2022.102604_bb0115","first-page":"6337","article-title":"Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV","volume":"181","author":"Yasui","year":"2008","journal-title":"J Immunol Baltim Md 1950"},{"issue":"1","key":"10.1016\/j.nano.2022.102604_bb0120","doi-asserted-by":"crossref","first-page":"15701","DOI":"10.1038\/s41598-018-34171-7","article-title":"Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis","volume":"8","author":"Kirchdoerfer","year":"2018","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.nano.2022.102604_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252849","article-title":"Immunogenic amino acid motifs and linear epitopes of COVID-19 mRNA vaccines. Ito E, ed","volume":"16","author":"Wisnewski","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nano.2022.102604_bb0130","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3389\/fimmu.2018.00826","article-title":"Editorial: epitope discovery and synthetic vaccine design","volume":"9","author":"Palatnik-de-Sousa","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.nano.2022.102604_bb0135","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1038\/s41598-019-39299-8","article-title":"Designing a multi-epitope based vaccine to combat Kaposi Sarcoma utilizing immunoinformatics approach","volume":"9","author":"Chauhan","year":"2019","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.nano.2022.102604_bb0140","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/s41423-020-00523-5","article-title":"Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients","volume":"17","author":"Li","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"10.1016\/j.nano.2022.102604_bb0145","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.imlet.2004.01.006","article-title":"The pan HLA DR-binding epitope improves adjuvant-assisted immunization with a recombinant protein containing a malaria vaccine candidate","volume":"92","author":"Rosa","year":"2004","journal-title":"Immunol Lett"},{"key":"10.1016\/j.nano.2022.102604_bb0150","article-title":"Gold nanoparticle-based platforms for vaccine development","author":"Mateu Ferrando","year":"2021","journal-title":"Drug Discov Today Technol"},{"issue":"10","key":"10.1016\/j.nano.2022.102604_bb0155","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/glycob\/cwt053","article-title":"The polysaccharide inulin is characterized by an extensive series of periodic isoforms with varying biological actions","volume":"23","author":"Cooper","year":"2013","journal-title":"Glycobiology"},{"key":"10.1016\/j.nano.2022.102604_bb0160","series-title":"Cell Imaging Techniques","first-page":"295","article-title":"Mica functionalization for imaging of DNA and protein-DNA complexes with atomic force microscopy","volume":"931","author":"Shlyakhtenko","year":"2012"},{"issue":"28","key":"10.1016\/j.nano.2022.102604_bb0165","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1021\/jacs.7b04885","article-title":"Freezing Directed Construction of Bio\/Nano Interfaces: Reagentless Conjugation, Denser Spherical Nucleic Acids, and Better Nanoflares","volume":"139","author":"Liu","year":"2017","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nano.2022.102604_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102715","article-title":"Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses","volume":"124","author":"Kannan","year":"2021","journal-title":"J Autoimmun"},{"issue":"7","key":"10.1016\/j.nano.2022.102604_bb0175","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41423-020-0374-2","article-title":"Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein","volume":"17","author":"Xia","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.nano.2022.102604_bb0180","doi-asserted-by":"crossref","first-page":"13120","DOI":"10.1038\/s41598-021-92641-x","article-title":"Natural variants in SARS-CoV-2 Spike protein pinpoint structural and functional hotspots with implications for prophylaxis and therapeutic strategies","volume":"11","author":"Pokhrel","year":"2021","journal-title":"Sci Rep"},{"issue":"13","key":"10.1016\/j.nano.2022.102604_bb0185","doi-asserted-by":"crossref","first-page":"108915","DOI":"10.1016\/j.celrep.2021.108915","article-title":"Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients","volume":"34","author":"Li","year":"2021","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.nano.2022.102604_bb0190","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem Sci"},{"issue":"5","key":"10.1016\/j.nano.2022.102604_bb0195","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00520-19","article-title":"Glycoconjugates: what it would take to master these well-known yet little-understood immunogens for vaccine development. Papasian CJ, ed","volume":"4","author":"Avci","year":"2019","journal-title":"mSphere"},{"issue":"6","key":"10.1016\/j.nano.2022.102604_bb0200","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41551-020-0572-3","article-title":"An optimized antigen\u2013protein fusion","volume":"4","author":"Romero","year":"2020","journal-title":"Nat Biomed Eng"},{"issue":"1\u20136","key":"10.1016\/j.nano.2022.102604_bb0205","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1699-0463.1996.tb00696.x","article-title":"A comparison of the immunogenicity of the native and denatured forms of a protein","volume":"104","author":"Koch","year":"1996","journal-title":"APMIS"},{"issue":"8","key":"10.1016\/j.nano.2022.102604_bb0210","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1021\/nl301877k","article-title":"A DNA Nanostructure Platform for Directed Assembly of Synthetic Vaccines","volume":"12","author":"Liu","year":"2012","journal-title":"Nano Lett"},{"issue":"33","key":"10.1016\/j.nano.2022.102604_bb0215","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1016\/j.vaccine.2010.02.103","article-title":"Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies","volume":"28","author":"Jegerlehner","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2022.102604_bb0220","series-title":"Clinical Applications of Immunomics","first-page":"39","article-title":"Epitope-based immunome-derived vaccines: a strategy for improved design and safety","author":"De Groot","year":"2009"},{"issue":"8","key":"10.1016\/j.nano.2022.102604_bb0225","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1080\/21645515.2016.1160977","article-title":"The promise and challenge of epitope-focused vaccines","volume":"12","author":"Oscherwitz","year":"2016","journal-title":"Hum Vaccines Immunother"},{"issue":"5","key":"10.1016\/j.nano.2022.102604_bb0230","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrd2224","article-title":"More than one reason to rethink the use of peptides in vaccine design","volume":"6","author":"Purcell","year":"2007","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.nano.2022.102604_bb0235","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1874279301810010047","article-title":"Peptide vaccines: new trends for avoiding the autoimmune response","volume":"10","author":"Raj\u010d\u00e1ni","year":"2018","journal-title":"Open Infect Dis J"},{"issue":"4","key":"10.1016\/j.nano.2022.102604_bb0240","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.vaccine.2006.08.013","article-title":"Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity","volume":"25","author":"Huleatt","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.nano.2022.102604_bb0245","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1182\/blood-2012-02-413831","article-title":"TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell\u2013independent isotype switch in mice","volume":"121","author":"Pihlgren","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.nano.2022.102604_bb0250","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/vaccines8010128","article-title":"Better adjuvants for better vaccines: progress in adjuvant delivery systems, modifications, and adjuvant-antigen codelivery","volume":"8","author":"Wang","year":"2020","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.nano.2022.102604_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/cpmc.105","article-title":"Two detailed plaque assay protocols for the quantification of infectious SARS-CoV-2","volume":"57","author":"Mendoza","year":"2020","journal-title":"Curr Protoc Microbiol"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963422000909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963422000909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:32:53Z","timestamp":1778617973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963422000909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":51,"alternative-id":["S1549963422000909"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2022.102604","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modular nanoarray vaccine for SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2022.102604","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102604"}}